These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 16043358
1. Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor kappaB transactivation. Liu H, Liu K, Bodenner DL. Cytokine; 2005 Aug 21; 31(4):251-7. PubMed ID: 16043358 [Abstract] [Full Text] [Related]
2. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells. Gionet N, Jansson D, Mader S, Pratt MA. J Cell Biochem; 2009 Jun 01; 107(3):448-59. PubMed ID: 19350539 [Abstract] [Full Text] [Related]
3. Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-kappaB. Harant H, Lindley IJ. Nucleic Acids Res; 2004 Jun 01; 32(17):5280-90. PubMed ID: 15466594 [Abstract] [Full Text] [Related]
4. The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes. Rascle A, Neumann T, Raschta AS, Neumann A, Heining E, Kastner J, Witzgall R. Exp Cell Res; 2009 Jan 01; 315(1):76-96. PubMed ID: 18996370 [Abstract] [Full Text] [Related]
5. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Kim DW, Gazourian L, Quadri SA, Romieu-Mourez R, Sherr DH, Sonenshein GE. Oncogene; 2000 Nov 16; 19(48):5498-506. PubMed ID: 11114727 [Abstract] [Full Text] [Related]
6. The classical and a non-classical pathways associated with NF-kappaB are involved in estrogen-mediated regulation of calbindin-D9k gene in rat pituitary cells. Lee GS, Choi KC, Han HJ, Jeung EB. Mol Cell Endocrinol; 2007 Oct 15; 277(1-2):42-50. PubMed ID: 17825480 [Abstract] [Full Text] [Related]
7. Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-kappaB pathway in breast cancer. Chavey C, Mühlbauer M, Bossard C, Freund A, Durand S, Jorgensen C, Jobin C, Lazennec G. Mol Pharmacol; 2008 Nov 15; 74(5):1359-66. PubMed ID: 18669446 [Abstract] [Full Text] [Related]
8. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity. Nishinakamura H, Minoda Y, Saeki K, Koga K, Takaesu G, Onodera M, Yoshimura A, Kobayashi T. Int Immunol; 2007 May 15; 19(5):609-19. PubMed ID: 17383969 [Abstract] [Full Text] [Related]
9. DNA-binding ability of NF-kappaB is affected differently by ERalpha and ERbeta and its activation results in inhibition of estrogen responsiveness. Guzeloglu-Kayisli O, Halis G, Taskiran S, Kayisli UA, Arici A. Reprod Sci; 2008 May 15; 15(5):493-505. PubMed ID: 18579858 [Abstract] [Full Text] [Related]
10. RhoA mediates angiotensin II-induced phospho-Ser536 nuclear factor kappaB/RelA subunit exchange on the interleukin-6 promoter in VSMCs. Cui R, Tieu B, Recinos A, Tilton RG, Brasier AR. Circ Res; 2006 Sep 29; 99(7):723-30. PubMed ID: 16960103 [Abstract] [Full Text] [Related]
11. Diarctigenin, a lignan constituent from Arctium lappa, down-regulated zymosan-induced transcription of inflammatory genes through suppression of DNA binding ability of nuclear factor-kappaB in macrophages. Kim BH, Hong SS, Kwon SW, Lee HY, Sung H, Lee IJ, Hwang BY, Song S, Lee CK, Chung D, Ahn B, Nam SY, Han SB, Kim Y. J Pharmacol Exp Ther; 2008 Nov 29; 327(2):393-401. PubMed ID: 18694995 [Abstract] [Full Text] [Related]
12. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding. Van Laere SJ, Van der Auwera I, Van den Eynden GG, Elst HJ, Weyler J, Harris AL, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY. Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3249-56. PubMed ID: 16740744 [Abstract] [Full Text] [Related]
13. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation. Griffin BD, Moynagh PN. Biochem J; 2006 Nov 15; 400(1):115-25. PubMed ID: 16792530 [Abstract] [Full Text] [Related]
14. The nuclear I kappaB protein I kappaB zeta specifically binds NF-kappaB p50 homodimers and forms a ternary complex on kappaB DNA. Trinh DV, Zhu N, Farhang G, Kim BJ, Huxford T. J Mol Biol; 2008 May 23; 379(1):122-35. PubMed ID: 18436238 [Abstract] [Full Text] [Related]
15. Estrogen receptor-independent inhibition of tumor necrosis factor-alpha gene expression by phytoestrogen equol is mediated by blocking nuclear factor-kappaB activation in mouse macrophages. Kang JS, Yoon YD, Han MH, Han SB, Lee K, Kang MR, Moon EY, Jeon YJ, Park SK, Kim HM. Biochem Pharmacol; 2005 Dec 19; 71(1-2):136-43. PubMed ID: 16288994 [Abstract] [Full Text] [Related]
16. Lipopolysaccharide-induced transcriptional activation of interleukin-10 is mediated by MAPK- and NF-kappaB-induced CCAAT/enhancer-binding protein delta in mouse macrophages. Liu YW, Chen CC, Tseng HP, Chang WC. Cell Signal; 2006 Sep 19; 18(9):1492-500. PubMed ID: 16413748 [Abstract] [Full Text] [Related]
17. [Effects of different nuclear factor kappaB dimers on the survival of immortalized neural progenitor cells]. Gui LL, Zhang CH, Liu ZH, Chen ZJ, Zhu C. Zhonghua Yi Xue Za Zhi; 2008 Apr 01; 88(13):871-5. PubMed ID: 18756949 [Abstract] [Full Text] [Related]
18. Transactivation of fibronectin promoter by HTLV-I Tax through NF-kappaB pathway. Yi T, Lee BH, Park RW, Kim IS. Biochem Biophys Res Commun; 2000 Sep 24; 276(2):579-86. PubMed ID: 11027516 [Abstract] [Full Text] [Related]
19. Quercetin 3-O-beta-(2''-galloyl)-glucopyranoside inhibits endotoxin LPS-induced IL-6 expression and NF-kappa B activation in macrophages. Kim BH, Lee IJ, Lee HY, Han SB, Hong JT, Ahn B, Lee CK, Kim Y. Cytokine; 2007 Sep 24; 39(3):207-15. PubMed ID: 17855110 [Abstract] [Full Text] [Related]
20. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Jiang J, Slivova V, Sliva D. Int J Oncol; 2006 Sep 24; 29(3):695-703. PubMed ID: 16865287 [Abstract] [Full Text] [Related] Page: [Next] [New Search]